1. Home
  2. ACOG vs QNCX Comparison

ACOG vs QNCX Comparison

Compare ACOG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • QNCX
  • Stock Information
  • Founded
  • ACOG 2000
  • QNCX 2012
  • Country
  • ACOG Canada
  • QNCX United States
  • Employees
  • ACOG N/A
  • QNCX N/A
  • Industry
  • ACOG
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACOG
  • QNCX Health Care
  • Exchange
  • ACOG Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • ACOG 91.6M
  • QNCX 70.4M
  • IPO Year
  • ACOG N/A
  • QNCX 2019
  • Fundamental
  • Price
  • ACOG $5.80
  • QNCX $1.60
  • Analyst Decision
  • ACOG
  • QNCX Strong Buy
  • Analyst Count
  • ACOG 0
  • QNCX 4
  • Target Price
  • ACOG N/A
  • QNCX $9.50
  • AVG Volume (30 Days)
  • ACOG 122.5K
  • QNCX 143.6K
  • Earning Date
  • ACOG 11-15-2024
  • QNCX 03-31-2025
  • Dividend Yield
  • ACOG N/A
  • QNCX N/A
  • EPS Growth
  • ACOG N/A
  • QNCX N/A
  • EPS
  • ACOG N/A
  • QNCX N/A
  • Revenue
  • ACOG N/A
  • QNCX N/A
  • Revenue This Year
  • ACOG N/A
  • QNCX N/A
  • Revenue Next Year
  • ACOG N/A
  • QNCX N/A
  • P/E Ratio
  • ACOG N/A
  • QNCX N/A
  • Revenue Growth
  • ACOG N/A
  • QNCX N/A
  • 52 Week Low
  • ACOG $4.66
  • QNCX $0.51
  • 52 Week High
  • ACOG $7.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • QNCX 43.92
  • Support Level
  • ACOG N/A
  • QNCX $1.49
  • Resistance Level
  • ACOG N/A
  • QNCX $1.69
  • Average True Range (ATR)
  • ACOG 0.00
  • QNCX 0.14
  • MACD
  • ACOG 0.00
  • QNCX 0.00
  • Stochastic Oscillator
  • ACOG 0.00
  • QNCX 46.15

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: